blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3852724

EP3852724 - CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  17.05.2024
Database last updated on 24.08.2024
FormerRequest for examination was made
Status updated on  25.06.2021
FormerThe international publication has been made
Status updated on  28.03.2020
Most recent event   Tooltip23.05.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
ACADIA Pharmaceuticals Inc.
12830 El Camino Real, Suite 400
San Diego, CA 92130 / US
[2023/12]
Former [2021/30]For all designated states
Levo Therapeutics, Inc.
5215 Old Orchard Road, Suite 965
Skokie, IL 60077 / US
Inventor(s)01 / BRYANT, Christopher
c/o Levo Therapeutics, Inc. 5215 Old Orchard Road
450
Skokie, Illinois 60077 / US
02 / MANNING, Mark C.
c/o Levo Therapeutics, Inc. 5215 Old Orchard Road
450
Skokie, Illinois 60077 / US
03 / HOLCOMB, Ryan E.
c/o Levo Therapeutics, Inc. 5215 Old Orchard Road
450
Skokie, Illinois 60077 / US
 [2021/30]
Representative(s)Maiwald GmbH
Grünstraße 25
40212 Düsseldorf / DE
[N/P]
Former [2021/30]Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
Application number, filing date19862482.720.09.2019
[2021/30]
WO2019US52092
Priority number, dateUS201862734134P20.09.2018         Original published format: US 201862734134 P
US201962876870P22.07.2019         Original published format: US 201962876870 P
[2021/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020061416
Date:26.03.2020
Language:EN
[2020/13]
Type: A1 Application with search report 
No.:EP3852724
Date:28.07.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 26.03.2020 takes the place of the publication of the European patent application.
[2021/30]
Search report(s)International search report - published on:US26.03.2020
(Supplementary) European search report - dispatched on:EP09.06.2022
ClassificationIPC:A61K9/08, A61K38/095, A61K47/38
[2022/27]
CPC:
A61K9/08 (EP,IL,KR,US); A61K38/095 (EP,IL,KR,US); A61K47/22 (IL,KR,US);
A61K47/26 (IL,KR,US); A61K47/38 (EP,IL,KR,US); A61K9/0043 (KR);
A61P25/00 (KR) (-)
Former IPC [2021/30]A61K9/08, A61K38/095
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/30]
TitleGerman:CARBETOCIN-ARZNEIMITTELPRODUKT UND VERFAHREN ZU SEINER HERSTELLUNG[2021/30]
English:CARBETOCIN DRUG PRODUCT AND PROCESS FOR PREPARING SAME[2021/30]
French:PRODUIT MÉDICAMENTEUX À LA CARBÉTOCINE ET SON PROCÉDÉ DE PRÉPARATION[2021/30]
Entry into regional phase19.04.2021National basic fee paid 
19.04.2021Search fee paid 
19.04.2021Designation fee(s) paid 
19.04.2021Examination fee paid 
Examination procedure19.04.2021Examination requested  [2021/30]
20.12.2022Amendment by applicant (claims and/or description)
22.05.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
22.09.2021Renewal fee patent year 03
27.09.2022Renewal fee patent year 04
27.09.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2012172304  (LEONARD ALEXIS KAYS [US], et al) [Y] 1-17 * page 8, paragraph 72 * * page 3, paragraphs 19-29 * * pages 12-14, paragraph 114; example 1; table 1 * * page 15; example 2; table 2 * * pages 21-22, paragraph 165; examples 5-6 * * Formulation 7; page 30; table 33 *;
 [XY]  - HØGSTEDT ULRICH B. ET AL, "Manipulating Aggregation Behavior of the Uncharged Peptide Carbetocin", JOURNAL OF PHARMACEUTICAL SCIENCES, US, vol. 107, no. 3, doi:10.1016/j.xphs.2017.11.008, ISSN 0022-3549, (20171121), pages 838 - 847, URL: https://jpharmsci.org/action/showPdf?pii=S0022-3549(17)30830-4, (20220524), XP055925065 [X] 1,2,7,8,14 * abstract * * page 839, column left, paragraph last - page 839, column right, paragraph 2 * * figure 2 * * table 2 * [Y] 1-17

DOI:   http://dx.doi.org/10.1016/j.xphs.2017.11.008
International search[A]US2004235956  (QUAY STEVEN C [US]) [A] 1-4, 18-19, 22-26, 28-29, 31-35, 37-39, 42/18-19, 42/22, 43/18-19, 43/22, 44/18-19, 44/22, 45/44/18-19, 45/44/22, 46/18-19, 46/22, 47/18-19, 47/22 * ; abstract; paragraphs [0015], [0020], [0041], [0047], [0081]-[0083] *;
 [XY]WO2008042452  (NASTECH PHARM CO [US], et al) [X] 5-9 * ; abstract; page 8, lines 8-10; page 11, lines 10-13; page 16, lines 14-24; page 18, lines 13-19; page 30, lines 10-13; page 41, lines 14-22; page 42, lines 5-12; page 54, table 23; claim 1 * [Y] 10-17;
 [A]US2010311655  (LEONARD ALEXIS KAYS [US], et al) [A] 1-4, 18-19, 22-26, 28-29, 31-35, 37-39, 42/18-19, 42/22, 43/18-19, 43/22, 44/18-19, 44/22, 45/44/18-19, 45/44/22, 46/18-19, 46/22, 47/18-19, 47/22* ; paragraphs [0014], [0038], [0049], [0057], [0093] *;
 [Y]WO2012042371  (FERRING BV [NL], et al) [Y] 11-13, 15-17 * ; page 5, lines 17-21; page 3, lines 31-33; page 4, lines 4-6; page 5, lines 17-25; page 24, lines 25-36; page 25, lines 1-5 *;
 [Y]WO2014107231  (ACIEX THERAPEUTICS INC [US]) [Y] 11-17 * ; paragraph [00382] *;
 [X]US2017326200  (DANGLAS PASCAL [CH], et al) [X] 48-49, 50/48-49 * ; paragraphs [0007), [0028], [0030], [0032], [0037], [0044], [0056], [0064]-[0065], [0095]-[0097] *;
 [Y]WO2018158234  (DUTCH RENEWABLE ENERGY B V [NL]) [Y] 10-17 * ; abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.